Sterile product manufacturing technology
Frieben, W.R.; Enzinger, R.M.
Journal of Parenteral Science and Technology a Publication of the Parenteral Drug Association 46(3): 85-86
1992
ISSN/ISBN: 0279-7976 PMID: 1522442 Document Number: 395901
Document emailed within 1 workday
Related Documents
Fornabaio, T.A. 1970: Design and operation of a new sterile manufacturing facility Bulletin of the Parenteral Drug Association 24(3): 110-118Kotaski, J.A. 1971: Elimination of contamination from personnel in sterile manufacturing areas Bulletin of the Parenteral Drug Association 25(4): 203-207
Mikhaĭlitsyn, F.S.; Petrov, I.F.; Bol'shakova, A.I.; Lebedeva, M.N.; Lychko, N.D. 1995: The technology for manufacturing antiparasitic preparations. 4. the development of a technology for producing the anthelmintic bromoksan in finely dispersed form and the evaluation of its antifascioliasis activity Meditsinskaia Parazitologiia i Parazitarnye Bolezni 3: 41-42
Romano, J.W.; Van Damme, L.; Hillier, S. 2014: The future of multipurpose prevention technology product strategies: understanding the market in parallel with product development Bjog: An International Journal of Obstetrics and Gynaecology 121 Suppl. 5: 15-18
Mikhaĭlitsyn, F.S.; Drusviatskaia, S.K.; Uvarova, N.A.; Taits, S.Z.; Stoianovich, F.M.; Vol'kenshteĭn, I.B.; Lebedeva, M.N.; Krotov, A.I.; Lychko, N.D. 1994: The technology for manufacturing antiparasitic preparations. 3. the development of a technology for producing the anthelmintic embovin (pyrantel embonate) in finely dispersed form and the evaluation of its anthelmintic properties Meditsinskaia Parazitologiia i Parazitarnye Bolezni 2: 24-26
Atkinson, E.M.; Christensen, J.R. 1999: Process and product development in the manufacturing of molecular therapeutics Idrugs: the Investigational Drugs Journal 2(10): 1031-1038
Schwartz, L.D. 1991: Good manufacturing practices equal product quality and consumer protection Journal of the American Veterinary Medical Association 198(5): 835
Mollica, J.A.; Lin, K.S. 1971: Parenteral formulation V: development of analytical methods for a sterile product Bulletin of the Parenteral Drug Association 25(3): 140-148
Rodrigues, L.O.; Alves, T.P.; Cardoso, J.P.; Menezes, J.é C. 2006: Improving drug manufacturing with process analytical technology Idrugs: the Investigational Drugs Journal 9(1): 44-48
Li, L.; Renard, J.J.; White, D.J. 2003: Sterile water for injection field technology (SWIFT) Aviation Space and Environmental Medicine 74(7): 803
Dévay, A.; Schaffer, M.; Kovács, P.; Rácz, I. 1988: Application of a factorial experimental project for optimization of manufacturing technology for theophylline suppositories Acta Pharmaceutica Hungarica 58(5): 201-207
Gopienko, N.A. 1979: Experience in using electronic computer technology in the medical health unit of the Ufa Motor Building Manufacturing Association Zdravookhranenie Rossiiskoi Federatsii 1979(7): 27-30
Li, C.; Cai, Y.C.; Wang, W.; Li, Q.L.; Zhou, Y.Q.; Liu, J.F.; Shui, C.Y.; Huang, L.; Deng, M.; Zhu, G.Q.; Liu, K.; Wang, S.X.; Chen, J.; Sun, R.H. 2016: Reconstruct the complex defects of mandible individually by computer-aided design and manufacturing technology: a case report Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 51(10): 780-782
Romano, J.; Manning, J.; Hemmerling, A.; McGrory, E.; Holt, B.Young. 2013: Prioritizing multipurpose prevention technology development and investments using a target product profile Antiviral Research 100 Suppl: S32-S38
Carapeti, E.A.; Andrews, S.M.; Bentley, P.G. 1996: Randomised study of sterile versus non-sterile urethral catheterisation Annals of the Royal College of Surgeons of England 78(1): 59-60
Allen, L.V. 2019: Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding International Journal of Pharmaceutical Compounding 23(5): 399-402
Kircik, L.H. 2013: Over-the-counter product role in the daily management of atopic dermatitis: achieving success with advanced technology Journal of Drugs in Dermatology: Jdd 12(7): S84
De Lucca, A.J.; Boue, S.M.; Carter-Wientjes, C.; Bhatnagar, D. 2012: Volatile profiles and aflatoxin production by toxigenic and non-toxigenic isolates of Aspergillus flavus grown on sterile and non-sterile cracked corn Annals of Agricultural and Environmental Medicine: Aaem 19(1): 91-98
Allen, L.V.; Okeke, C.C. 2008: Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 9: immediate use compounded sterile preparations International Journal of Pharmaceutical Compounding 12(5): 440-443
Jørgensen, M.S.; Jørgensen, U. 2009: Green technology foresight of high technology: a social shaping of technology approach to the analysis of hopes and hypes Technology Analysis-Strategic Management 21(3): 363-379